inflammation

January 24, 2023

Study reveals new therapeutic target to subdue autoimmune inflammation caused by loss of regulatory T cell function.

July 28, 2022

Genetically modified mouse studies reveal pathways for organ-damaging autoimmune response.

July 12, 2022

Let the bacteria do the work by feeding them right, advises UW Medicine gastrointestinalist. 

May 6, 2021

Researchers are looking at whether their findings could be used for developing therapeutics for patients in the future. 

picture of lab technician processing COVID-19 sample
April 15, 2021

A study just underway at UW Medicine is evaluating whether a lab-formulated monoclonal antibody could curb the over-amplified inflammatory response that some patients experience with COVID-19 pneumonia.  The researchers are evaluating the drug's

April 8, 2021

Study findings may help explain patients' poor concentration and other cognitive symptoms that accompany sinusitis. 

February 26, 2018

Recent findings in mice suggest a new approach to test in protecting  people with diabetes from their higher risk of advanced blood vessel disease, which sets the stage for early heart attacks and strokes. 

 

A new study by University of Washington researchers reveals how cells keep inflammation in check by secreting protein antagonists that bind to and block inflammatory signals from white cells. 

A new Center for Innate Immunity and Immune Disease at UW Medicine seeks to become a world leader in finding therapies to regulate the body’s defense system and fend off a wide variety of diseases.

A team of researchers including Jeff McLean of the University of Washington has published dramatic new findings on bacteria that are detectable but have evaded cultivation in the lab.

Pages

Subscribe to inflammation